Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selegiline Patch for Nicotine Dependence
NCT01330030Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jul 2005
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selegiline in nicotine dependence, sponsored by Stanford University. Started Jul 2005; status: completed.
02
Drugs
selegiline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01330030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01330030.